Exsilio Therapeutics
Boston, United States· Est.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Total funding raised: $82M
Overview
Engineering precision gene therapies to provide durable cures for inherited genetic diseases.
Genetics & Genomics
Technology Platform
A versatile platform for viral vector design and/or gene editing aimed at safe and efficient delivery of genetic cargo to target tissues.
Funding History
1Total raised:$82M
Seed$82M
Opportunities
Potential to achieve transformative, one-time cures for diseases with no effective treatments, commanding significant value.
Risk Factors
High development costs, complex manufacturing, safety concerns around immunogenicity and genotoxicity, and uncertain long-term durability.
Competitive Landscape
Enters a highly competitive and fast-moving gene therapy landscape, requiring differentiation in vector design, targeting, or manufacturing.